Results of a tapered cementless femoral stem implanted in varus.

J Arthroplasty

Wellington Orthopaedic and Sports Medicine, Cincinnati, Ohio 45247, USA.

Published: June 2002

Varus placement of the femoral component in total hip arthroplasty has been associated with poor outcomes. The purpose of this study was to examine results of total hip arthroplasty with varus alignment of a tapered titanium femoral prosthesis (Alloclassic; Sulzer, Zurich, Switzerland) at a minimum 5-year follow-up. Of a consecutive series of 585 patients, 23 met the inclusion criteria. Harris hip scores averaged 97, and all implants were clinically and radiographically stable at the most recent follow-up. In this series of patients, varus alignment of the prosthesis did not have an adverse effect on outcome. Although malalignment of the femoral prosthesis may compromise the results of some designs, the Alloclassic prosthesis has proved to be reliable and forgiving despite varus malalignment at 5 to 11 years' follow-up.

Download full-text PDF

Source
http://dx.doi.org/10.1054/arth.2002.32171DOI Listing

Publication Analysis

Top Keywords

total hip
8
hip arthroplasty
8
varus alignment
8
femoral prosthesis
8
varus
5
tapered cementless
4
femoral
4
cementless femoral
4
femoral stem
4
stem implanted
4

Similar Publications

Background: Telerehabilitation is gaining popularity in European and American countries, but whether it can be successfully implemented in China still lacks support from clinical studies.

Objective: This trial aimed to determine if a home-based telerehabilitation method is clinically noninferior to standard in-hospital face-to-face rehabilitation for elderly patients with total hip arthroplasty (THA) in China.

Methods: This multicenter randomized controlled trial was conducted from January 2021 to June 2022 at The First Rehabilitation Hospital in Shanghai, Shanghai Jiao Tong University affiliated Sixth People's Hospital and Shanghai Tongji University affiliated Tenth People's Hospital.

View Article and Find Full Text PDF

This study aimed to assess pain intensity in patients who underwent total hip arthroplasty (THA) using the Visual Analogue Scale (VAS). The study was conducted between 2022 and 2023, enrolling 203 patients admitted to the Orthopedics Department. Participants self-reported their post-surgical pain 24 hours after THA by selecting a VAS rating that best represented their personal experience.

View Article and Find Full Text PDF

Purpose: To describe diagnostic approaches and management strategies for patients with primary hyperparathyroidism (PHPT) and recent fracture in England.

Methods: We developed a survey based on a patient at high fracture risk and a new diagnosis of probable PHPT. The survey was circulated among 50 secondary care professionals identified by the Society for Endocrinology Calcium and Bone special interest group.

View Article and Find Full Text PDF

Study Design: Retrospective observational study.

Objective: To evaluate whether the combined American Spine Registry and Medicare (ASR/CMS) data yields substantially different findings versus ASR data alone with regard to key parameters such as risk stratification, complication rates and readmission rates in lumbar surgery investigated through an analysis of 8,755 spondylolisthesis cases.

Summary Of Background Data: Medicare data correlation has been effective for determining revision rates for other procedures such as total hip replacement.

View Article and Find Full Text PDF

Background: Quadriceps dysfunction is ubiquitous after anterior cruciate ligament (ACL) reconstruction (ACLR). Addressing quadriceps dysfunction is crucial to improve function, reduce the reinjury risk, and maintain long-term knee health. While deficits specific to the quadriceps are well documented, less is known about the effect of an ACL injury on other lower extremity muscle groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!